Neurofibromatosis Type I and Multiple Gastrointestinal Stromal Tumors: A Unique Identity

Authors

  • Joana Espiga de Macedo Consultant of Medical Oncologist, Department of Medical Oncology, Centro Hospitalar de Entre, Douro e Vouga, Portugal

DOI:

https://doi.org/10.17140/CSMMOJ-3-117

Abstract

Von Recklinghausen’s disease (VRD) is a genetic disorder characterized by the growth of multiple noncancerous tumors of nerves and skin (neurofibromas) and areas of hypo or hyperpigmentation of the skin. It is also known as Neurofibromatosis type I (NF1) and represents one type of VRD. It is an autosomal dominant disorder with a rate of occurrence of 1 in 3000 in the general population.1 The cause of NF1 is a mutation in the NF1 gene, located at the chromosome 17q11.2, which encodes the tumor suppressor gene, neurofibromin. Loss of neurofibromin function results in activity of Ras oncogene and consequently tumor formation.

References

Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR. Multiple gastrointestinal stromal tumors in type I neuro-fibromatosis: A pathologic and molecular study. Mod Pathol. 2005; 18(4): 475-484. doi: 10.1038/modpathol.3800334

Tomatsu M, Isogaki J, Watanabe T, et al. Multiple gastric gas-trointestinal stromal tumors in a patient with neurofibromato-sis type 1. Case Reports in Surgery. 2016; 2016: 1515202. doi: 10.1155/2016/1515202

Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. The Lancet; 2013; 382(9896): 973-983, doi: 10.1016/S0140-6736(13)60106-3

Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function muta-tions of c-kit in human gastrointestinal stromal tumors. Science. 1998; 279(5350): 577-580. doi: 10.1126/science.279.5350.577

Corless CL. Gastrointestinal stromal tumors: What do we know now? Mod Pathol. 2014; 27: S1-S16: doi: 10.1038/mod-pathol.2013.173

Downloads

Published

2017-05-16

How to Cite

Joana Espiga de Macedo. (2017). Neurofibromatosis Type I and Multiple Gastrointestinal Stromal Tumors: A Unique Identity. Cancer Studies and Molecular Medicine , 3(2), 19–20. https://doi.org/10.17140/CSMMOJ-3-117

Issue

Vol. 3 No. 2 (2017): Volume 3 Issue 2 2017

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Cancer Studies and Molecular Medicine (CSMM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.